John Overdeck’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-33,313
Closed -$140K 3015
2021
Q4
$140K Buy
33,313
+14,034
+73% +$78.7K ﹤0.01% 3996
2021
Q3
$157K Sell
19,279
-56,075
-74% -$456K ﹤0.01% 4018
2021
Q2
$569K Sell
75,354
-49,962
-40% -$421K ﹤0.01% 2982
2021
Q1
$1.09M Buy
125,316
+48,385
+63% +$461K ﹤0.01% 2231
2020
Q4
$613K Sell
76,931
-52,627
-41% -$440K ﹤0.01% 2355
2020
Q3
$1.03M Buy
129,558
+54,539
+73% +$492K ﹤0.01% 1733
2020
Q2
$743K Buy
+75,019
New +$689K ﹤0.01% 1730
2020
Q1
Sell
-108,693
Closed -$418K 3231
2019
Q4
$418K Buy
+108,693
New +$474K ﹤0.01% 2931
2019
Q3
Sell
-18,132
Closed -$120K 3511
2019
Q2
$120K Sell
18,132
-32,890
-64% -$226K ﹤0.01% 3180
2019
Q1
$386K Buy
51,022
+17,477
+52% +$136K ﹤0.01% 2433
2018
Q4
$271K Buy
33,545
+19,843
+145% +$197K ﹤0.01% 2522
2018
Q3
$177K Sell
13,702
-178,231
-93% -$2.23M ﹤0.01% 3030
2018
Q2
$2.19M Buy
191,933
+97,320
+103% +$921K 0.01% 1546
2018
Q1
$667K Buy
+94,613
New +$715K ﹤0.01% 2283

Other funds holding CTSO

John Overdeck's CTSO Position: Q1 2022 in Review

John Overdeck sold out of Cytosorbents Corp (CTSO) in Q1 2022, closing a stake of 33,313 shares — an estimated $140K sold.

John Overdeck first reported a position in CTSO in Q1 2018 and held it in 14 quarters. The position peaked at $2.19M in Q2 2018. 88 funds tracked by Wall St. Rank hold CTSO as of Q1 2022.

  • John Overdeck reported no remaining Cytosorbents Corp position as of Q1 2022 after selling out during the quarter.
  • John Overdeck sold 33,313 Cytosorbents Corp shares in Q1 2022, an estimated $140K.
  • John Overdeck first reported a position in Cytosorbents Corp in Q1 2018 and held it in 14 quarters.
  • John Overdeck's Cytosorbents Corp position peaked at $2.19M in Q2 2018.
  • 88 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.